Clinical Trials Browser

Phase 3 × Leukemia, Lymphocytic, Chronic, B-Cell × dinaciclib × Clear all

NCT01580228 2017-02-23

A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell